Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 907 of 5804
-
Genetic test may spare thousands of women from unnecessary radiation
Disease control Recruiting nowTo evaluate whether the combination of clinicopathological factors and the use of the Oncotype DX DCIS score can avoid radiation in women with low risk DCIS who have had breast conserving surgery (BCS)
Sponsor: Ontario Clinical Oncology Group (OCOG) • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Supercharged immune cells take on tough melanoma
Disease control CompletedThe purpose of this first in human study is to evaluate the feasibility, safety, and efficacy of administering TBio-4101 (tumor infiltrating lymphocytes \[TIL\]) after receiving a lymphodepleting chemotherapy regimen and before receiving interleukin-2 (IL-2) in participants with …
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug targets wasting syndrome in cancer patients
Symptom relief CompletedStudy to evaluate the efficacy, safety and tolerability of ponsegromab compared to placebo in patients with cancer, cachexia, and elevated GDF 15.
Phase: PHASE2 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Saving the ligament: a trial tests whether repairing a torn ACL beats replacing it
Disease control Recruiting nowBackground: Arthroscopic anterior cruciate ligament(ACL) reconstruction is so far the gold standard for the treatment of ACL ruptures, but this technique still suffers from problems of tendon-bone healing, bone tunnel enlargement, bone resorption, a low rate of return to motion,e…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New 6-Month shot shows promise for prostate cancer control
Disease control CompletedThe main aim of this study is to assess the effectiveness and safety of the 6-month formulation of triptorelin pamoate in Chinese participants with locally advanced or metastatic cancer of the prostate. Participants will receive 1 injection of triptorelin pamoate 6-month formulat…
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Jun 26, 2026 14:39 UTC
-
Could a pacemaker boost exercise capacity in adults with a rare heart condition?
Disease control CompletedThe main objective of RIGHT-CRT is to assess the impact/efficacy of CRT on functional capacity in ACHD patients with SRV.
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New depression drug shows promise in large trial
Symptom relief CompletedDemonstrate ability of SEP-363856 to be superior to placebo as an adjunctive therapy to ADT in change from baseline in depressive symptoms (MADRS \& CGI-S) in MDD patients who had an inadequate response to prior ADT therapy.
Phase: PHASE2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New shot could tame stubborn high blood pressure
Disease control CompletedThe purpose of this 20-week randomized double-blind study in patients with resistant hypertension (rHTN) is to evaluate the efficacy, safety, and tolerability, of different doses of XXB750 administered as subcutaneous (SC) injections, compared to placebo. Since all study particip…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for migraine sufferers: rimegepant shows promise in prevention trial
Disease control CompletedThis study is being conducted to evaluate the efficacy and tolerability of rimegepant for migraine prophylaxis in adults with a history of inadequate response to oral preventive medications
Phase: PHASE4 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New mRNA flu shot shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThe main purpose of the study is to evaluate the safety, reactogenicity, and the humoral immunogenicity of mRNA-1010 and comparator influenza vaccines against homologous influenza A and B strains at Day 29.
Phase: PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:59 UTC
-
Could a laser ease painful sex for millions of women?
Symptom relief CompletedThis is a multicenter randomized controlled trial (RCT) investigating the effects of laser treatments in women suffering from provoked vestibulodynia compared to a sham-laser treatment. Following their enrollment in the study, participants will undergo a gynecological examination…
Phase: NA • Sponsor: Université de Sherbrooke • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Overnight DNA test could speed up cancer care for kids
Knowledge-focused Recruiting nowCambridge University Hospitals NHS Foundation Trust (CUHNFT) is the Principal Treatment Centre for the East of England region, responsible for 120-150 patients \<16 years with a new diagnosis of paediatric malignancy annually; leukaemia comprises \~25% of these cases. Current mol…
Sponsor: University of Cambridge • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
One-Day fix for spinal tumors? new trial combines surgery and radiation
Symptom relief Recruiting nowThe BLEND RCT aims to evaluate the (cost-)effectiveness of same-day SBRT and surgical stabilization with or without decompression for the treatment of symptomatic, unstable spinal metastases on physical functioning four weeks after the start of treatment, compared with the standa…
Phase: NA • Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Tailored heart procedure aims to beat atrial fibrillation
Disease control Recruiting nowAtrial fibrillation (AF) is the most common arrhythmia with an expected rise in prevalence over the next decade. Catheter ablation is a safe treatment option in eliminating AF however, success rates still remains variable. Existing strategies do not take into account the differen…
Phase: NA • Sponsor: Barts & The London NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Hope for pompe patients: could a switch in enzyme therapy slow decline?
Disease control OngoingThe goal of this clinical trial is to study the efficacy and safety of treatment with avalglucosidase alfa in patients with late onset Pompe disease that previously deteriorated on alglucosidase alfa. The main question it aims to answer is: * Is switching to avalglucosidase alf…
Phase: PHASE4 • Sponsor: Iris Plug • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple nutritional plan boost survival after liver procedure?
Disease control Recruiting nowThe hypothesis is that in patients with cirrhosis and refractory ascites candidate to TIPS, and sarcopenia (identified by a PMA ≤16 cm² at the level of L3), who are at high-risk of 6-month mortality after TIPS placement, a post-TIPS 12 weeks nutritional intervention is associated…
Phase: PHASE3 • Sponsor: The Mediterranean Institute for Transplantation and Advanced Specialized Therapies • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could two years of hormone therapy be enough for some breast cancers?
Disease control Recruiting nowHormone therapy is recommended for five years in all patients with hormone receptor-positive breast cancer, but there is no consensus on its duration in low-risk tumours and especially in postmenopausal women. Adjuvant endocrine therapy (ET) is associated with substantial side ef…
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Peanut allergy pill shows promise in early trial
Disease control CompletedA study to evaluate the safety, efficacy and tolerability of remibrutinib at three doses versus placebo in adult participants who have a confirmed allergy to peanuts. The efficacy was measured by the ability of participants to tolerate increasing doses of peanut protein during an…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Weight loss pill shows promise in major trial
Disease control CompletedThis study will look how well semaglutide tablets taken once daily helps people with body weight above the healthy range. Participants will either get semaglutide 25 milligram (mg) once daily or placebo once daily. This study will last for 72 weeks, which includes 1-week screenin…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could early Blood-Pressure drugs be a Game-Changer for sepsis?
Disease control Recruiting nowSepsis is a life-threatening reaction to an infection. It happens when the immune system overreacts to an infection and starts to damage the body's tissues and organs. The aim of this research study is to compare the two different ways to treat sepsis, in the early phase of trea…
Phase: PHASE3 • Sponsor: NHS Greater Glasgow and Clyde • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC